Ilorasertib hydrochloride

Modify Date: 2024-01-09 18:52:27

Ilorasertib hydrochloride Structure
Ilorasertib hydrochloride structure
Common Name Ilorasertib hydrochloride
CAS Number 1847485-91-9 Molecular Weight 525.00
Density N/A Boiling Point N/A
Molecular Formula C25H22ClFN6O2S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Ilorasertib hydrochloride


Ilorasertib hydrochloride (ABT-348 hydrochloride) is a potent and ATP-competitive multitargeted kinase inhibitor, which inhibits Aurora C, Aurora B, and Aurora A with IC50s of 1 nM, 7 nM, 120 nM, respectively. Ilorasertib hydrochloride (ABT-348 hydrochloride) also suppresses RET tyrosine kinase, PDGFRβ and Flt1 with IC50s of 7 nM, 3 nM and 32 nM, respectively[1].

 Names

Name Ilorasertib hydrochloride

 Ilorasertib hydrochloride Biological Activity

Description Ilorasertib hydrochloride (ABT-348 hydrochloride) is a potent and ATP-competitive multitargeted kinase inhibitor, which inhibits Aurora C, Aurora B, and Aurora A with IC50s of 1 nM, 7 nM, 120 nM, respectively. Ilorasertib hydrochloride (ABT-348 hydrochloride) also suppresses RET tyrosine kinase, PDGFRβ and Flt1 with IC50s of 7 nM, 3 nM and 32 nM, respectively[1].
Related Catalog
Target

Aurora C:1 nM (IC50)

Aurora B:7 nM (IC50)

Aurora B (Y156H):12 nM (IC50)

Aurora A:120 nM (IC50)

PDGFRα:11 nM (IC50)

PDGFRβ:13 nM (IC50)

VEGFR1:1 nM (IC50)

VEGFR2:2 nM (IC50)

VEGFR3:43 nM (IC50)

FLT3:1 nM (IC50)

CSF-1R:3 nM (IC50)

c-KIT:20 nM (IC50)

References

[1]. Glaser KB, et al. Preclinical characterization of ABT-348, a kinase inhibitor targeting the aurora, vascular endothelial growth factor receptor/platelet-derived growth factor receptor, and Src kinase families. J Pharmacol Exp Ther. 2012 Dec;343(3):617-27.

 Chemical & Physical Properties

Molecular Formula C25H22ClFN6O2S
Molecular Weight 525.00